nanoNAD+™ Clinical Injectable & IV Infusion
$295.00 – $450.00 (Prescription Only)
nanoNAD+™ Clinical Injectable & IV Solution represents the clinical evolution of intravenous NAD+ therapy. Originally pioneered in the United States by Dr. Richard 'Dick' Mestayer and Dr. Fenton LeBon, this next-generation formulation utilizes declumped single-molecule dispersion to eliminate the intense chest pressure, stomach cramping, and vascular burning historically associated with raw NAD+ drips. Available in multidose subcutaneous vials (200mg/mL) and high-concentration clinical IV vials (400mg/mL).
How It's Different
Why single-molecule 1.92 nm stereochemical purity changes cellular absorption kinetics.
Eliminates the painful injection burning and infusion discomfort caused by clumped, polymeric NAD+ aggregates triggering vascular endothelial spasms.
100% bioactive Beta-NAD+ delivering immediate electron-transport Complex I substrate without competing toxic Alpha stereoisomers.
Produced without chemical reducing agents or synthetic adulterants; buffered to physiological pH for smooth subcutaneous or intravenous infusion.
Who It's For
- Patients requiring rapid systemic bioenergetic restoration for chronic fatigue, post-viral depletion, or cellular senescence.
- Longevity clinics and functional wellness centers looking to offer high-tolerance, comfortable NAD+ protocols.
- Individuals preferring convenient at-home daily subcutaneous micro-dosing under physician supervision.
How To Use
Prescription only. Subcutaneous micro-dosing: 25–100mg daily. IV Infusion: 250–500mg administered by a registered nurse.
Administer subcutaneously into abdominal subcutaneous tissue with a standard U-100 insulin syringe. For IV, infuse over 60–90 minutes.
Strictly refrigerated at 2–8 °C. Inspect vial clarity prior to administration.
Analytical Quality Documentation
PTL ID: 544383-88 (Certified Light Scattering)
100.0% single-molecule hydrodynamic volume (1.924 nm).
Sterile USP <797> compounded, endotoxin tested, potency verified.
HPLC Stereoisomer Confirmed
1.92 nm Single-Molecule
Zero Polymeric Aggregation
Batch Verified
Complete 503A batch testing verifying sterile multi-dose vial seal integrity, pH stability, and HPLC purity.
Frequently Asked Questions
Why does traditional NAD+ IV therapy cause severe cramping and chest tightness?
Traditional IV solutions use clumped raw NAD+ crystals that bind to peripheral vascular receptors and trigger sudden vasoconstriction and smooth muscle spasms. Because nanoNAD+™ consists of isolated 1.92 nm single molecules, it flows smoothly without triggering painful vascular spasms.
Can I do subcutaneous injections at home?
Yes, when prescribed by an affiliated healthcare provider. The 5mL 200mg/mL multidose vial allows comfortable daily subcutaneous injections using a virtually painless insulin needle.
How To Get It
Four direct pathways to acquire nanoNAD+™ formulations for personal recovery, patient care, or regional territory expansion.
Buy Online
Direct retail ordering for qualifying topical formulations via our authorized fulfillment portal.
Find a Center
Connect with an affiliated clinical hub or medical wellness clinic offering Dr. LeBon’s protocol.
Ask Your Provider
Provide your treating physician with our 503A compounding pharmacy curriculum and clinical dossier.
Provider Portal
Unlock wholesale practice pricing, clinical certification, and protected regional territory rights.